TrianglePomalidomide for HIV-associated… (NCT05389423)
Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for HIV associated B cell non Hodgkin lymphoma with high risk features, in adults.
The idea: add a study drug to chemotherapy. Non Hodgkin lymphoma is the most common cancer among people living with HIV in the United States, and the disease may differ in these two groups. Pomalidomide is tested with chemotherapy, with or without rituximab, at rising doses.
The trial plans 25 patients and studies safety first. At the National Institutes of Health Clinical Center in Bethesda, Ramya Ramaswami leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.